Mumbai, India

Nirogi Venkata Satya Ramakrishna

This inventor holds 2 USPTO granted patents. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2001-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nirogi Venkata Satya Ramakrishna. Retrieved from https://idiyas.com/inventor/nirogi-venkata-satya-ramakrishna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 11.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nirogi Venkata Satya Ramakrishna - Pioneering Inventor from Mumbai

Introduction: Nirogi Venkata Satya Ramakrishna is a renowned inventor hailing from Mumbai, India, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ramakrishna holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With over two decades of experience in the industry, Ramakrishna has worked with top research institutions and multinational companies, leading teams to develop cutting-edge solutions that have revolutionized various sectors.

Collaborations: Throughout his career, Ramakrishna has collaborated with leading universities, tech companies, and government agencies to drive innovation and bring his ideas to life through successful partnerships and projects.

Conclusion: Nirogi Venkata Satya Ramakrishna's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…